nodes	percent_of_prediction	percent_of_DWPC	metapath
Canagliflozin—ABCC2—bile canaliculus—sclerosing cholangitis	0.331	0.454	CbGeAlD
Canagliflozin—ABCC2—bile duct—sclerosing cholangitis	0.103	0.142	CbGeAlD
Canagliflozin—ORM1—bile—sclerosing cholangitis	0.0966	0.133	CbGeAlD
Canagliflozin—ABCC2—bile—sclerosing cholangitis	0.0793	0.109	CbGeAlD
Canagliflozin—UGT2B4—Farnesoid X Receptor  Pathway—ABCB4—sclerosing cholangitis	0.0711	0.261	CbGpPWpGaD
Canagliflozin—ORM1—gall bladder—sclerosing cholangitis	0.0268	0.0369	CbGeAlD
Canagliflozin—ALB—gall bladder—sclerosing cholangitis	0.0235	0.0323	CbGeAlD
Canagliflozin—UGT2B4—liver—sclerosing cholangitis	0.0219	0.0301	CbGeAlD
Canagliflozin—ABCC2—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.0193	0.0706	CbGpPWpGaD
Canagliflozin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.0161	0.0591	CbGpPWpGaD
Canagliflozin—UGT1A9—liver—sclerosing cholangitis	0.0149	0.0205	CbGeAlD
Canagliflozin—ABCB1—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.00906	0.0332	CbGpPWpGaD
Canagliflozin—UGT2B4—Phase II conjugation—GGT1—sclerosing cholangitis	0.00856	0.0314	CbGpPWpGaD
Canagliflozin—ORM1—liver—sclerosing cholangitis	0.00786	0.0108	CbGeAlD
Canagliflozin—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00758	0.0278	CbGpPWpGaD
Canagliflozin—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—sclerosing cholangitis	0.00744	0.0273	CbGpPWpGaD
Canagliflozin—SLC5A1—NRF2 pathway—GGT1—sclerosing cholangitis	0.00739	0.0271	CbGpPWpGaD
Canagliflozin—SLC5A2—NRF2 pathway—GGT1—sclerosing cholangitis	0.00739	0.0271	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00722	0.0265	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00722	0.0265	CbGpPWpGaD
Canagliflozin—ALB—liver—sclerosing cholangitis	0.00689	0.00948	CbGeAlD
Canagliflozin—UGT1A9—PPARA activates gene expression—ABCB4—sclerosing cholangitis	0.00646	0.0237	CbGpPWpGaD
Canagliflozin—ABCC2—liver—sclerosing cholangitis	0.00646	0.00888	CbGeAlD
Canagliflozin—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCB4—sclerosing cholangitis	0.00632	0.0232	CbGpPWpGaD
Canagliflozin—SLC5A2—Carbohydrate metabolism—GOT2—sclerosing cholangitis	0.00541	0.0198	CbGpPWpGaD
Canagliflozin—SLC5A1—Carbohydrate metabolism—GOT2—sclerosing cholangitis	0.00541	0.0198	CbGpPWpGaD
Canagliflozin—UGT2B4—Biological oxidations—GGT1—sclerosing cholangitis	0.00501	0.0184	CbGpPWpGaD
Canagliflozin—SLC5A1—Carbohydrate metabolism—GOT1—sclerosing cholangitis	0.00467	0.0171	CbGpPWpGaD
Canagliflozin—SLC5A2—Carbohydrate metabolism—GOT1—sclerosing cholangitis	0.00467	0.0171	CbGpPWpGaD
Canagliflozin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00467	0.0171	CbGpPWpGaD
Canagliflozin—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—ABCB4—sclerosing cholangitis	0.00436	0.016	CbGpPWpGaD
Canagliflozin—ABCB1—pancreas—sclerosing cholangitis	0.00365	0.00502	CbGeAlD
Canagliflozin—CYP3A4—liver—sclerosing cholangitis	0.00328	0.00451	CbGeAlD
Canagliflozin—UGT1A9—Phase II conjugation—GGT1—sclerosing cholangitis	0.00317	0.0116	CbGpPWpGaD
Canagliflozin—CYP3A4—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.00305	0.0112	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—ABCB4—sclerosing cholangitis	0.0027	0.00991	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—ABCB4—sclerosing cholangitis	0.0027	0.00991	CbGpPWpGaD
Canagliflozin—ABCB1—liver—sclerosing cholangitis	0.00232	0.00319	CbGeAlD
Canagliflozin—UGT1A9—NRF2 pathway—GGT1—sclerosing cholangitis	0.00211	0.00774	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—ABCB4—sclerosing cholangitis	0.00209	0.00765	CbGpPWpGaD
Canagliflozin—ABCC2—NRF2 pathway—GGT1—sclerosing cholangitis	0.00206	0.00756	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00203	0.00743	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00201	0.00738	CbGpPWpGaD
Canagliflozin—UGT1A9—Biological oxidations—GGT1—sclerosing cholangitis	0.00185	0.00679	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00174	0.00636	CbGpPWpGaD
Canagliflozin—ALB—Selenium Micronutrient Network—GGT1—sclerosing cholangitis	0.00166	0.00608	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—GOT2—sclerosing cholangitis	0.00153	0.00562	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—GOT2—sclerosing cholangitis	0.00153	0.00562	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—GOT1—sclerosing cholangitis	0.00132	0.00485	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—GOT1—sclerosing cholangitis	0.00132	0.00485	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—GOT2—sclerosing cholangitis	0.00128	0.00471	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—GOT2—sclerosing cholangitis	0.00128	0.00471	CbGpPWpGaD
Canagliflozin—ABCB1—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.00127	0.00466	CbGpPWpGaD
Canagliflozin—ABCB1—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.00116	0.00424	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—GOT1—sclerosing cholangitis	0.00111	0.00407	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—GGT1—sclerosing cholangitis	0.00111	0.00407	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—GOT1—sclerosing cholangitis	0.00111	0.00407	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—GGT1—sclerosing cholangitis	0.00111	0.00407	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00108	0.00396	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—GOT2—sclerosing cholangitis	0.000992	0.00364	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.000947	0.00347	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—HIF1A—sclerosing cholangitis	0.000921	0.00338	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—HIF1A—sclerosing cholangitis	0.000921	0.00338	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000908	0.00333	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—GOT1—sclerosing cholangitis	0.000856	0.00314	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—GGT1—sclerosing cholangitis	0.000856	0.00314	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—NOS2—sclerosing cholangitis	0.000838	0.00307	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—NOS2—sclerosing cholangitis	0.000838	0.00307	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ABCB4—sclerosing cholangitis	0.000773	0.00283	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000712	0.00261	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—GGT1—sclerosing cholangitis	0.000524	0.00192	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ABCB4—sclerosing cholangitis	0.000405	0.00148	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000373	0.00137	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—GOT2—sclerosing cholangitis	0.000367	0.00135	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ABCB4—sclerosing cholangitis	0.000354	0.0013	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—GGT1—sclerosing cholangitis	0.000317	0.00116	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—GOT1—sclerosing cholangitis	0.000317	0.00116	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—NOS2—sclerosing cholangitis	0.000259	0.000949	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ABCB4—sclerosing cholangitis	0.000218	0.000801	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GOT2—sclerosing cholangitis	0.000192	0.000705	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GOT2—sclerosing cholangitis	0.000168	0.000617	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GGT1—sclerosing cholangitis	0.000166	0.000608	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—GOT1—sclerosing cholangitis	0.000166	0.000608	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GGT1—sclerosing cholangitis	0.000145	0.000533	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—GOT1—sclerosing cholangitis	0.000145	0.000533	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GOT2—sclerosing cholangitis	0.000104	0.00038	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GGT1—sclerosing cholangitis	8.96e-05	0.000328	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—GOT1—sclerosing cholangitis	8.96e-05	0.000328	CbGpPWpGaD
